Research Antibodies & Reagents Market - Global Outlook & Forecast 2024-2029

List of Tables

The global research antibodies & reagents market was valued at USD 13.39 billion in 2023 and is expected to grow at a CAGR of 8.03% from 2023-2029.

MARKET TRENDS & DRIVERS

Growing Demand for Precision Medicine

Life sciences and healthcare have recently witnessed a significant shift towards precision medicine. This transformative approach to healthcare promises tailored individualized treatments based on a patient's unique genetic makeup, lifestyle, and environmental factors. Precision medicine can revolutionize disease diagnosis and treatment, making therapies more effective, reducing adverse effects, and improving patient outcomes. This paradigm shift presents a substantial opportunity for the research antibodies & reagents market, an essential component of precision medicine research. Further, precision medicine is characterized by the personalization of medical care. It leverages genetic and molecular information to tailor treatments to individual patients instead of a one-size-fits-all approach. This approach is becoming increasingly important, especially in the treatment of complex and genetically diverse diseases, such as cancer, cardiovascular disorders, and neurodegenerative conditions.

Rising Focus on Biomarker Discovery

Biomarker discovery has emerged as a dynamic and transformative trend within the research antibodies & reagents market. Biomarkers are biological molecules that offer critical insights into various aspects of health and disease. These molecules can include proteins, genes, metabolites, or other molecular indicators that provide valuable information about the body's physiological and pathological conditions. As the understanding of the role of biomarkers in research, diagnostics, and personalized medicine deepens, there is a growing focus on their discovery and application, reshaping the research antibodies & reagents market. Biomarkers are invaluable for the early and accurate diagnosis of diseases. They enable healthcare professionals to identify specific conditions and customize treatment plans.

Increase in Research Academies and Industry Collaborations

The life sciences and biotechnology field is amidst a revolutionary transformation, and the research antibodies & reagents market is at the heart of this change. The demand for high-quality research antibodies and reagents has increased significantly with the emphasis on precision medicine, personalized therapeutics, and advanced diagnostics. The growing collaboration between research academies and the biotechnology industry is a notable driving force behind this surge. Further, collaboration between research academies, such as universities and academic institutions, and the biotechnology industry has become a cornerstone of modern scientific progress. These partnerships bridge the gap between fundamental research and practical applications, ensuring that scientific discoveries are translated into tangible solutions for healthcare and other industries. In the context of research antibodies and reagents, these collaborations yield remarkable results.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

The reagents product type accounted for the most significant global research antibodies & reagents market share in 2023. Research reagents, often referred to as research materials or laboratory reagents, are the unsung heroes of scientific investigation. They are the critical components that enable researchers, scientists, and investigators to unlock the natural world's mysteries. The demand for research antibodies and reagents has witnessed a significant upswing in recent years, driven by the expanding scope of life sciences research, advancements in personalized medicine, and an increasing emphasis on understanding complex biological processes. These critical tools are integral to various applications, including immunology, cell biology, molecular biology, and genomics.

Ongoing technological advancements in antibody development and reagent manufacturing contribute to the diversification and improvement of research tools. The role of research antibodies and reagents in diagnostics has expanded, with applications ranging from immunoassays for disease detection to the development of diagnostic imaging agents. Collaborations between academic institutions, research organizations, and pharmaceutical companies have intensified. These partnerships drive collaborative research projects, creating a sustained demand for high-quality antibodies and reagents across various research domains.

Segmentation by Product Type

Reagents
- By Product Type
Media & Sera
Stains & Dyes
Buffers
Other
- Antibody
By Product
Primary
Secondary
By Form
Monoclonal
Polyclonal
By Source
Rabbit
Mouse
Rat
Other
By Research Area
Oncology
Infectious Diseases
Immunology
Neurobiology
Stem Cell
Other

INSIGHTS BY TECHNOLOGY

The global research antibodies & reagents market by technology is segmented into ELISA, flow cytometry, western blotting, immunofluorescence, immunohistochemistry, immunoprecipitation, and others. In 2023, the ELISA accounted for the most significant share of the global market. ELISA is a powerful and versatile biochemical technique to quantify and detect specific proteins, antigens, antibodies, and other biomolecules. It has become an indispensable tool for researchers, diagnostic laboratories, and the biotechnology industry, contributing significantly to life sciences and healthcare advancements. Over the years, ELISA has evolved and diversified, leading to various ELISA assays, including direct, indirect, sandwich, and competitive ELISAs. This versatility has made ELISA a fundamental technique in biomedical research. Further, western blotting technology is expected to register the highest CAGR in the research antibodies & reagents industry during the forecast period. Western blotting is a versatile and pivotal method and is often called immunoblotting. It is a powerful tool for detecting and quantifying specific proteins within complex biological samples.

Segmentation by Technology

ELISA
Flow Cytometry
Western Blotting
Immunofluorescence
Immunohistochemistry
Immunoprecipitation
Other

INSIGHTS BY APPLICATION

The global research antibodies & reagents market by application is segmented into proteomics, drug development, and genomics. In 2023, the proteomics application segment accounted for a significant global market share. Proteomics is a rapidly evolving field of scientific research focusing on the comprehensive study of proteins, their functions, and interactions within a biological system. It plays a pivotal role in understanding the molecular mechanisms of various diseases and has significant applications in drug development, diagnostics, and personalized medicine. The tools and technologies used in proteomics research, such as antibodies and reagents, have become integral components of the scientific toolbox. Also, the proteomics segment is expected to register the highest segmental CAGR in the global research antibodies & reagents market during the forecast period. Further, drug development relies heavily on understanding molecular targets, pathways, and interactions. Research antibodies and reagents are integral to drug discovery and development, contributing to target identification, validation, and preclinical and clinical studies. Antibodies and reagents in genomics applications contribute to understanding gene expression, regulation, and the functional elements within the genome.

Segmentation by Application

Proteomics
Drug Development
Genomics

INSIGHTS BY END-USER

The academics & research institutes and research labs end-user segment dominated the global research antibodies & reagents market share in 2023. Academics & research institutes play a pivotal role in advancing scientific knowledge. These institutions are engaged in fundamental research across various disciplines, including biology, chemistry, medicine, and environmental sciences. Research antibodies and reagents are pivotal components of life sciences research, enabling the detection and analysis of specific molecules, proteins, or genes within biological samples. These tools are indispensable for various applications, including immunohistochemistry, flow cytometry, Western blotting, and other assays. Further, the pharmaceutical and biotech sectors often require high throughput screening capabilities, driving the demand for antibodies and reagents suitable for large-scale experiments. CROs and CDMOs provide outsourced research, development, and manufacturing services to the pharmaceutical and biotechnology industries.

Segmentation by End-user

Academic & Research Institutes and Research Labs
Pharma & Biotech Companies
CROs & CDMOs

GEOGRAPHICAL ANALYSIS

North America holds the most prominent share of the global research antibodies & reagents market, accounting for over 39% in 2023. The U.S. and Canada are significant contributors to the North American market. The region boasts advanced healthcare infrastructure, extensive research activities, and a high demand for antibodies and reagents. The regional market is characterized by its dynamic nature, driven by a relentless pursuit of scientific innovation and the need for high-quality tools in life sciences research. North America boasts a thriving ecosystem of key market players, including renowned companies such as Thermo Fisher Scientific, Danaher, Bio-Rad Laboratories, and BD Biosciences. These companies are at the forefront of research and development, constantly introducing cutting-edge antibodies and reagents to meet the evolving demands of the scientific community.

Segmentation by Geography

North America
- The U.S.
- Canada
Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Russia
- Netherlands
APAC
- China
- Japan
- India
- South Korea
- Australia
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE

VENDOR LANDSCAPE

The global research antibodies & reagents market has witnessed significant growth, driven by increasing investment in life sciences research, advancements in personalized medicine, and a growing focus on understanding molecular and cellular processes. The rising demand for reliable and high-quality antibodies and reagents is a crucial factor shaping market dynamics. Furthermore, continuous technological advancements in antibody development and reagent manufacturing contribute to product innovation. Companies investing in research and development to enhance the specificity, sensitivity, and versatility of their products gain a competitive edge in meeting the evolving needs of researchers.

Key Company Profiles

Bio-Rad Laboratories
Bio-Techne
Danaher
F.Hoffmann La-Roche
Merck KGaA
Thermo Fisher Scientific

Other Prominent Vendors

Abcepta
Abclonal
Abnova
Atlas Antibodies
Aviva Systems Biology
Cell Signaling Technology
Cantata Bio
Fujirebio
GeneTex
GenScript
ICL
Jackson ImmunoResearch
MBL International
Omega Bio-tek
Proteintech Group
RayBiotech Life
ROCKLAND IMMUNOCHEMICALS
Santa Cruz Biotechnology
SOL Group
SouthernBiotech

KEY QUESTIONS ANSWERED:

1.How big is the research antibodies & reagents market?

2.What is the growth rate of the global research antibodies & reagents market?

3.Which region dominates the global research antibodies & reagents market share?

4.What are the significant trends in the research antibodies & reagents industry?

5.Who are the key players in the global research antibodies & reagents market?

Product Code: ARZ240116

1 SCOPE & COVERAGE

1.1 MARKET DEFINITION
- 1.1.1 INCLUSIONS
- 1.1.2 EXCLUSIONS
- 1.1.3 MARKET ESTIMATION CAVEATS
1.2 MARKET SEGMENTATION
- 1.2.1 MARKET BY PRODUCT
- 1.2.2 MARKET BY TECHNOLOGY
- 1.2.3 MARKET BY APPLICATION
- 1.2.4 MARKET BY END-USER
1.3 REGIONS & COUNTRIES COVERED
1.4 BASE YEAR
1.5 MARKET DERIVATION

2 PREMIUM INSIGHTS

2.1 OPPORTUNITY POCKETS
2.2 OVERVIEW
- 2.2.1 GEOGRAPHY INSIGHTS
- 2.2.2 PRODUCT TYPE INSIGHTS
- 2.2.3 TECHNOLOGY INSIGHTS
- 2.2.4 APPLICATION INSIGHTS
- 2.2.5 END-USER INSIGHTS

3 MARKET AT A GLANCE

4 INTRODUCTION

4.1 OVERVIEW
- 4.1.1 RESEARCH ANTIBODIES
- 4.1.2 RESEARCH REAGENTS

5 MARKET OPPORTUNITIES & TRENDS

5.1 GROWING DEMAND FOR PRECISION MEDICINE
5.2 INCREASING OUTSOURCING SERVICES TO CROS & CDMOS
5.3 GROWING STEM CELLS AND NEUROBIOLOGY RESEARCH
5.4 RISING FOCUS ON BIOMARKER DISCOVERY

6 MARKET GROWTH ENABLERS

6.1 INCREASE IN RESEARCH ACADEMIES AND INDUSTRY COLLABORATIONS
6.2 GROWING R&D AND RESEARCH FUNDING FOR ANTIBODY DEVELOPMENT
6.3 RISE IN PROTEOMICS AND GENOMICS RESEARCH

7 MARKET RESTRAINTS

7.1 QUALITY CONCERNS ASSOCIATED WITH RESEARCH ANTIBODIES & REAGENTS
7.2 COMPLEXITIES ASSOCIATED WITH METHOD OF ANTIBODY PRODUCTION
7.3 CHALLENGES ASSOCIATED WITH ALL RESEARCH ACTIVITIES
7.4 ETHICAL & REGULATORY ISSUES ASSOCIATED WITH ANIMAL-DERIVED MATERIALS AND REAGENTS

8 MARKET LANDSCAPE

8.1 MARKET OVERVIEW
8.2 MARKET SIZE & FORECAST
8.3 FIVE FORCES ANALYSIS
- 8.3.1 THREAT OF NEW ENTRANTS
- 8.3.2 BARGAINING POWER OF SUPPLIERS
- 8.3.3 BARGAINING POWER OF BUYERS
- 8.3.4 THREAT OF SUBSTITUTES
- 8.3.5 COMPETITIVE RIVALRY

9 PRODUCT

9.1 MARKET SNAPSHOT & GROWTH ENGINE
9.2 MARKET OVERVIEW

10 REAGENTS

10.1 MARKET OVERVIEW
10.2 MARKET SIZE & FORECAST
10.3 REAGENTS: PRODUCT SEGMENTATION
- 10.3.1 REAGENTS MARKET BY PRODUCT
- 10.3.2 MEDIA & SERA: MARKET SIZE & FORECAST
- 10.3.3 STAINS & DYES: MARKET SIZE & FORECAST
- 10.3.4 BUFFERS: MARKET SIZE & FORECAST
- 10.3.5 OTHERS: MARKET SIZE & FORECAST
- 10.3.6 REAGENTS MARKET BY GEOGRAPHY

11 ANTIBODY

11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.3 ANTIBODIES: PRODUCT
- 11.3.1 RESEARCH ANTIBODIES MARKET BY ANTIBODY TYPE
- 11.3.2 PRIMARY ANTIBODY: MARKET SIZE & FORECAST
- 11.3.3 SECONDARY ANTIBODY: MARKET SIZE & FORECAST
11.4 ANTIBODIES: FORM
- 11.4.1 RESEARCH ANTIBODIES MARKET BY FORM
- 11.4.2 MONOCLONAL ANTIBODY: MARKET SIZE & FORECAST
- 11.4.3 POLYCLONAL ANTIBODY: MARKET SIZE & FORECAST
11.5 ANTIBODIES: SOURCE
- 11.5.1 RESEARCH ANTIBODIES MARKET BY SOURCE
- 11.5.2 RABBIT: MARKET SIZE & FORECAST
- 11.5.3 MOUSE: MARKET SIZE & FORECAST
- 11.5.4 RAT: MARKET SIZE & FORECAST
- 11.5.5 OTHER: MARKET SIZE & FORECAST
11.6 RESEARCH AREA
- 11.6.1 ONCOLOGY: MARKET SIZE & FORECAST
- 11.6.2 INFECTIOUS DISEASES: MARKET SIZE & FORECAST
- 11.6.3 IMMUNOLOGY: MARKET SIZE & FORECAST
- 11.6.4 NEUROBIOLOGY: MARKET SIZE & FORECAST
- 11.6.5 STEM CELL: MARKET SIZE & FORECAST
- 11.6.6 OTHER: MARKET SIZE & FORECAST
- 11.6.7 RESEARCH ANTIBODIES MARKET BY RESEARCH AREA
- 11.6.8 ANTIBODY MARKET BY GEOGRAPHY

12 TECHNOLOGY

12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 ELISA
- 12.3.1 MARKET OVERVIEW
- 12.3.2 MARKET SIZE & FORECAST
- 12.3.3 ELISA MARKET BY GEOGRAPHY
12.4 FLOW CYTOMETRY
- 12.4.1 MARKET OVERVIEW
- 12.4.2 MARKET SIZE & FORECAST
- 12.4.3 FLOW CYTOMETRY MARKET BY GEOGRAPHY
12.5 WESTERN BLOTTING
- 12.5.1 MARKET OVERVIEW
- 12.5.2 MARKET SIZE & FORECAST
- 12.5.3 WESTERN BLOTTING MARKET BY GEOGRAPHY
12.6 IMMUNOFLUORESCENCE
- 12.6.1 MARKET OVERVIEW
- 12.6.2 MARKET SIZE & FORECAST
- 12.6.3 IMMUNOFLUORESCENCE MARKET BY GEOGRAPHY
12.7 IMMUNOHISTOCHEMISTRY
- 12.7.1 MARKET OVERVIEW
- 12.7.2 MARKET SIZE & FORECAST
- 12.7.3 IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY
12.8 IMMUNOPRECIPITATION
- 12.8.1 MARKET OVERVIEW
- 12.8.2 MARKET SIZE & FORECAST
- 12.8.3 IMMUNOPRECIPITATION MARKET BY GEOGRAPHY
12.9 OTHER
- 12.9.1 MARKET OVERVIEW
- 12.9.2 MARKET SIZE & FORECAST
- 12.9.3 OTHER MARKET BY GEOGRAPHY

13 APPLICATION

13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PROTEOMICS
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 PROTEOMICS MARKET BY GEOGRAPHY
13.4 DRUG DEVELOPMENT
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 DRUG DEVELOPMENT MARKET BY GEOGRAPHY
13.5 GENOMICS
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 GENOMICS MARKET BY GEOGRAPHY

14 END-USER

14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS MARKET BY GEOGRAPHY
14.4 PHARMA & BIOTECH COMPANIES
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 PHARMA & BIOTECH COMPANIES MARKET BY GEOGRAPHY
14.5 CROS & CDMOS
- 14.5.1 MARKET OVERVIEW
- 14.5.2 MARKET SIZE & FORECAST
- 14.5.3 CROS & CDMOS MARKET BY GEOGRAPHY

15 GEOGRAPHY

15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 GEOGRAPHIC OVERVIEW

16 NORTH AMERICA

16.1 MARKET OVERVIEW
16.2 MARKET SIZE & FORECAST
- 16.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
- 16.2.2 NORTH AMERICA MARKET BY TECHNOLOGY
- 16.2.3 NORTH AMERICA MARKET BY APPLICATION
- 16.2.4 NORTH AMERICA MARKET BY END-USER
16.3 KEY COUNTRIES
- 16.3.1 US: MARKET SIZE & FORECAST
- 16.3.2 CANADA: MARKET SIZE & FORECAST

17 EUROPE

17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
- 17.2.1 EUROPE MARKET BY PRODUCT TYPE
- 17.2.2 EUROPE MARKET BY TECHNOLOGY
- 17.2.3 EUROPE MARKET BY APPLICATION
- 17.2.4 EUROPE MARKET BY END-USER
17.3 KEY COUNTRIES
- 17.3.1 GERMANY: MARKET SIZE & FORECAST
- 17.3.2 UK: MARKET SIZE & FORECAST
- 17.3.3 FRANCE: MARKET SIZE & FORECAST
- 17.3.4 ITALY: MARKET SIZE & FORECAST
- 17.3.5 SPAIN: MARKET SIZE & FORECAST
- 17.3.6 RUSSIA: MARKET SIZE & FORECAST
- 17.3.7 NETHERLANDS: MARKET SIZE & FORECAST

18 APAC

18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
- 18.2.1 APAC MARKET BY PRODUCT TYPE
- 18.2.2 APAC MARKET BY TECHNOLOGY
- 18.2.3 APAC MARKET BY APPLICATION
- 18.2.4 APAC MARKET BY END-USER
18.3 KEY COUNTRIES
- 18.3.1 CHINA: MARKET SIZE & FORECAST
- 18.3.2 JAPAN: MARKET SIZE & FORECAST
- 18.3.3 INDIA: MARKET SIZE & FORECAST
- 18.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
- 18.3.5 AUSTRALIA: MARKET SIZE & FORECAST

19 LATIN AMERICA

19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
- 19.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
- 19.2.2 LATIN AMERICA MARKET BY TECHNOLOGY
- 19.2.3 LATIN AMERICA MARKET BY APPLICATION
- 19.2.4 LATIN AMERICA MARKET BY END-USER
19.3 KEY COUNTRIES
- 19.3.1 BRAZIL: MARKET SIZE & FORECAST
- 19.3.2 MEXICO: MARKET SIZE & FORECAST
- 19.3.3 ARGENTINA: MARKET SIZE & FORECAST
- 19.3.4 COLOMBIA: MARKET SIZE & FORECAST

20 MIDDLE EAST & AFRICA

20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
- 20.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
- 20.2.2 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
- 20.2.3 MIDDLE EAST & AFRICA MARKET BY APPLICATION
- 20.2.4 MIDDLE EAST & AFRICA MARKET BY END-USER
20.3 KEY COUNTRIES
- 20.3.1 TURKEY: MARKET SIZE & FORECAST
- 20.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
- 20.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
- 20.3.4 UAE: MARKET SIZE & FORECAST

21 COMPETITIVE LANDSCAPE

21.1 COMPETITION OVERVIEW

22 MARKET SHARE ANALYSIS

22.1.1 BIO-RAD LABORATORIES
22.1.2 BIO-TECHNE
22.1.3 DANAHER
22.1.4 F. HOFFMANN LA-ROCHE
22.1.5 MERCK KGAA
22.1.6 THERMO FISHER SCIENTIFIC

23 KEY COMPANY PROFILES

23.1 BIO-RAD LABORATORIES
- 23.1.1 BUSINESS OVERVIEW
- 23.1.2 PRODUCT OFFERINGS
- 23.1.3 KEY STRATEGIES
- 23.1.4 KEY STRENGTHS
- 23.1.5 KEY OPPORTUNITIES
23.2 BIO-TECHNE
- 23.2.1 BUSINESS OVERVIEW
- 23.2.2 PRODUCT OFFERINGS
- 23.2.3 KEY STRATEGIES
- 23.2.4 KEY STRENGTHS
- 23.2.5 KEY OPPORTUNITIES
23.3 DANAHER
- 23.3.1 BUSINESS OVERVIEW
- 23.3.2 PRODUCT OFFERINGS
- 23.3.3 KEY STRATEGIES
- 23.3.4 KEY STRENGTHS
- 23.3.5 KEY OPPORTUNITIES
23.4 F. HOFFMANN LA-ROCHE
- 23.4.1 BUSINESS OVERVIEW
- 23.4.2 PRODUCT OFFERINGS
- 23.4.3 KEY STRATEGIES
- 23.4.4 KEY STRENGTHS
- 23.4.5 KEY OPPORTUNITIES
23.5 MERCK KGAA
- 23.5.1 BUSINESS OVERVIEW
- 23.5.2 PRODUCT OFFERINGS
- 23.5.3 KEY STRATEGIES
- 23.5.4 KEY STRENGTHS
- 23.5.5 KEY OPPORTUNITIES
23.6 THERMO FISHER SCIENTIFIC
- 23.6.1 BUSINESS OVERVIEW
- 23.6.2 PRODUCT OFFERINGS
- 23.6.3 KEY STRATEGIES
- 23.6.4 KEY STRENGTHS
- 23.6.5 KEY OPPORTUNITIES

24 OTHER PROMINENT VENDORS

24.1 ABCEPTA
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
24.2 ABCLONCAL
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
24.3 ABNOVA
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
24.4 ATLAS ANTIBODIES
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
24.5 AVIVA SYSTEMS BIOLOGY
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
24.6 CELL SIGNALING TECHNOLOGY
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 PRODUCT OFFERINGS
24.7 CANTATA BIO
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
24.8 FUJIREBIO
- 24.8.1 BUSINESS OVERVIEW
- 24.8.2 PRODUCT OFFERINGS
24.9 GENETEX
- 24.9.1 BUSINESS OVERVIEW
- 24.9.2 PRODUCT OFFERINGS
24.10 GENSCRIPT
- 24.10.1 BUSINESS OVERVIEW
- 24.10.2 PRODUCT OFFERINGS
24.11 ICL
- 24.11.1 BUSINESS OVERVIEW
- 24.11.2 PRODUCT OFFERINGS
24.12 JACKSON IMMUNORESEARCH
- 24.12.1 BUSINESS OVERVIEW
- 24.12.2 PRODUCT OFFERINGS
24.13 MBL INTERNATIONAL
- 24.13.1 BUSINESS OVERVIEW
- 24.13.2 PRODUCT OFFERINGS
24.14 OMEGA BIO-TEK
- 24.14.1 BUSINESS OVERVIEW
- 24.14.2 PRODUCT OFFERINGS
24.15 PROTEINTECH GROUP
- 24.15.1 BUSINESS OVERVIEW
- 24.15.2 PRODUCT OFFERINGS
24.16 RAYBIOTECH LIFE
- 24.16.1 BUSINESS OVERVIEW
- 24.16.2 PRODUCT OFFERINGS
24.17 ROCKLAND IMMUNOCHEMICALS
- 24.17.1 BUSINESS OVERVIEW
- 24.17.2 PRODUCT OFFERINGS
24.18 SANTA CRUZ BIOTECHNOLOGY
- 24.18.1 BUSINESS OVERVIEW
- 24.18.2 PRODUCT OFFERINGS
24.19 SOL GROUP
- 24.19.1 BUSINESS OVERVIEW
- 24.19.2 PRODUCT OFFERINGS
24.20 SOUTHERNBIOTECH
- 24.20.1 BUSINESS OVERVIEW
- 24.20.2 PRODUCT OFFERINGS

25 REPORT SUMMARY

25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS

26 QUANTITATIVE SUMMARY

26.1 MARKET BY PRODUCT TYPE
- 26.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
- 26.1.2 EUROPE MARKET BY PRODUCT TYPE
- 26.1.3 APAC MARKET BY PRODUCT TYPE
- 26.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
- 26.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
26.2 MARKET BY TECHNOLOGY
- 26.2.1 NORTH AMERICA MARKET BY TECHNOLOGY
- 26.2.2 EUROPE MARKET BY TECHNOLOGY
- 26.2.3 APAC MARKET BY TECHNOLOGY
- 26.2.4 LATIN AMERICA MARKET BY TECHNOLOGY
- 26.2.5 MIDDLE EAST & AFRICA MARKET BY TECHNOLOGY
26.3 MARKET BY APPLICATION
- 26.3.1 NORTH AMERICA MARKET BY APPLICATION
- 26.3.2 EUROPE MARKET BY APPLICATION
- 26.3.3 APAC MARKET BY APPLICATION
- 26.3.4 LATIN AMERICA MARKET BY APPLICATION
- 26.3.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
26.4 MARKET BY END-USER
- 26.4.1 NORTH AMERICA MARKET BY END-USER
- 26.4.3 EUROPE MARKET BY END-USER
- 26.4.4 APAC MARKET BY END-USER
- 26.4.6 LATIN AMERICA MARKET BY END-USER
- 26.4.7 MIDDLE EAST & AFRICA MARKET BY END-USER
26.5 MARKET BY GEOGRAPHY
- 26.5.1 REAGENTS MARKET BY GEOGRAPHY
- 26.5.2 ANTIBODY MARKET BY GEOGRAPHY
- 26.5.3 ELISA MARKET BY GEOGRAPHY
- 26.5.4 FLOW CYTOMETRY MARKET BY GEOGRAPHY
- 26.5.5 WESTERN BLOTTING MARKET BY GEOGRAPHY
- 26.5.6 IMMUNOFLUORESCENCE MARKET BY GEOGRAPHY
- 26.5.7 IMMUNOHISTOCHEMISTRY MARKET BY GEOGRAPHY
- 26.5.8 IMMUNOPRECIPITATION MARKET BY GEOGRAPHY
- 26.5.9 OTHER MARKET BY GEOGRAPHY
- 26.5.10 PROTEOMICS MARKET BY GEOGRAPHY
- 26.5.11 DRUG DEVELOPMENT MARKET BY GEOGRAPHY
- 26.5.12 GENOMICS MARKET BY GEOGRAPHY
- 26.5.13 ACADEMIC & RESEARCH INSTITUTES AND RESEARCH LABS MARKET BY GEOGRAPHY
- 26.5.14 PHARMA & BIOTECH COMPANIES MARKET BY GEOGRAPHY
- 26.5.15 CROS & CDMOS MARKET BY GEOGRAPHY

27 APPENDIX

27.1 RESEARCH METHODOLOGY
27.2 RESEARCH PROCESS
27.3 REPORT ASSUMPTIONS & CAVEATS
- 27.3.1 KEY CAVEATS
- 27.3.2 CURRENCY CONVERSION
27.4 ABBREVIATIONS